- Home
- NEWT vs OABI Comparison
NEWT vs OABI Comparison
Compare NEWT & OABI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEWT
- OABI
- Stock Information
- Founded
- NEWT 1998
- OABI 2012
- Country
- NEWT United States
- OABI United States
- Employees
- NEWT N/A
- OABI N/A
- Industry
- NEWT Major Banks
- OABI Biotechnology: Pharmaceutical Preparations
- Sector
- NEWT Finance
- OABI Health Care
- Exchange
- NEWT Nasdaq
- OABI Nasdaq
- Market Cap
- NEWT 294.8M
- OABI 250.8M
- IPO Year
- NEWT N/A
- OABI N/A
- Fundamental
- Price
- NEWT $11.66
- OABI $1.97
- Analyst Decision
- NEWT Hold
- OABI Strong Buy
- Analyst Count
- NEWT 4
- OABI 3
- Target Price
- NEWT $13.00
- OABI $6.67
- AVG Volume (30 Days)
- NEWT 249.9K
- OABI 546.1K
- Earning Date
- NEWT 07-28-2025
- OABI 08-06-2025
- Dividend Yield
- NEWT 6.52%
- OABI N/A
- EPS Growth
- NEWT 27.62
- OABI N/A
- EPS
- NEWT 1.92
- OABI N/A
- Revenue
- NEWT $352,584,000.00
- OABI $23,027,000.00
- Revenue This Year
- NEWT N/A
- OABI N/A
- Revenue Next Year
- NEWT $13.51
- OABI $45.02
- P/E Ratio
- NEWT $6.05
- OABI N/A
- Revenue Growth
- NEWT 23.06
- OABI 6.05
- 52 Week Low
- NEWT $9.12
- OABI $1.22
- 52 Week High
- NEWT $15.49
- OABI $4.87
- Technical
- Relative Strength Index (RSI)
- NEWT 54.84
- OABI 52.18
- Support Level
- NEWT $11.05
- OABI $1.69
- Resistance Level
- NEWT $11.44
- OABI $2.08
- Average True Range (ATR)
- NEWT 0.34
- OABI 0.12
- MACD
- NEWT -0.03
- OABI -0.02
- Stochastic Oscillator
- NEWT 55.45
- OABI 57.00
About NEWT NewtekOne Inc.
NewtekOne Inc is a financial holding company engaged in providing financial solutions to its Client Base. It is an internally managed non-diversified closed-end management investment company. It has four reportable segments Banking, Alternative Lending, Technology, NSBF, and Payments.
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.